1. Home
  2. Stock quotes
  3. Align Technology
  4. Financial Ratios
Align Technology logo
Align Technology ALGN
$ 163.38 5.3%

Quarterly report 2026-Q1
added 05-06-2026

report update icon

Align Technology Financial Ratios 2011-2026 | ALGN

Annual Financial Ratios Align Technology

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

P/E

 31.6 33.1 52.0 66.0 67.2 23.7 47.2 46.6 93.5 37.9 36.7 29.4 73.3 40.2 29.7 14.7 -27.7 10.9 -

P/S

 3.2 3.5 6.0 6.4 13.1 17.0 8.7 9.5 14.7 6.7 6.3 5.6 7.1 4.2 4.1 2.8 2.8 2.9 -

EPS

 5.7 5.6 5.8 4.6 9.8 22.6 5.6 5 2.9 2.4 1.8 1.8 0.8 0.7 0.9 1.0 -0.5 1.2 -

EV (Enterprise Value)

 14 B 15.2 B 24.7 B 25.3 B 53.1 B 42.7 B 21.5 B 18.8 B 21.8 B 7.2 B 5.43 B 4.32 B 4.67 B 2.23 B 1.9 B 895 M 783 M 785 M -89.1 M

EBITDA per Share

 10.8 10.1 10.3 9.83 13.8 6.1 7.47 6.51 4.89 3.42 2.58 2.62 2.21 1.56 1.19 1.51 -0.34 0.38 -

EV/EBITDA

 17.9 20.3 31.4 32.9 48.9 84.1 34.3 34.5 54.1 24.9 24.8 19.3 25.1 16.3 18.7 7.8 -32.9 30.8 -

PEG

 1.48 2.05 2.66 2.61 1.7 1.13 4.14 0.64 4.36 1.18 -66.5 0.23 7.64 -2.66 -2.42 - - - -

P/B

 3.2 3.6 6.4 6.6 14.3 13.0 15.5 14.9 18.8 7.2 6.2 5.7 7.4 4.1 4.0 2.9 3.2 - -

P/CF

 21.8 18.9 29.4 42.0 44.2 63.6 34.9 56.3 89.1 40.6 28.7 21.1 28.3 24.7 19.8 8.4 11.7 22.0 -

ROE %

 10.13 10.93 12.26 10.05 21.31 54.92 32.89 31.94 20.12 19.06 16.98 19.37 10.14 10.10 13.59 19.66 -8.28 36.60 -

ROA %

 6.58 6.77 7.31 6.09 12.99 36.77 17.71 19.50 13.02 13.59 12.43 14.76 7.73 7.76 10.28 15.57 -8.80 - -

ROCE %

 13.48 15.77 17.72 17.84 26.95 11.97 33.63 34.30 27.62 23.89 21.27 24.62 24.55 20.35 18.03 27.20 -9.00 7.10 -

Current Ratio

 2.9 2.6 2.5 2.5 2.6 3.0 1.7 1.9 2.3 2.7 2.7 3.3 3.1 3.1 2.6 4.8 4.3 - -

DSO

 94.9 86.7 83.3 85.9 71.8 89.2 94.2 81.5 80.0 83.6 68.4 62.2 62.6 64.5 69.6 56.6 31.9 - -

DIO

 66.3 83.8 100.4 94.3 66.3 64.7 61.7 39.2 32.4 37.4 34.6 31.7 31.5 38.4 29.0 10.0 4.7 - -

DPO

 31.7 33.7 38.1 48.4 54.9 59.1 48.0 45.2 37.7 39.4 85.6 57.7 46.1 57.0 68.8 30.3 14.2 - -

Operating Cycle

 161.1 170.5 183.7 180.2 138.1 153.9 155.9 120.6 112.4 121.1 103.0 93.9 94.1 102.9 98.6 66.6 36.6 - -

Cash Conversion Cycle

 129.4 136.8 145.7 131.8 83.2 94.8 107.8 75.4 74.8 81.6 17.4 36.2 47.9 46.0 29.9 36.3 22.4 - -

All numbers in USD currency

Quarterly Financial Ratios Align Technology

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2

EPS

 1.58 0.78 1.72 1.27 - 1.55 1.28 1.4 - 1.59 1.46 1.14 - 0.93 1.44 1.71 - 2.29 2.53 2.54 - 1.77 -0.52 19.32 - 1.29 1.84 0.9 - 1.26 1.32 1.2 - 1.03 0.86 0.87 - 0.64 0.63 0.51 - 0.35 0.39 0.45 - 0.47 0.44 0.4 - 0.43 0.36 -0.52 - - 0.35 0.26 - 0.25 0.14 0.21 0.22 0.43

EBITDA per Share

 2.78 2.1 2.81 2.31 - 2.68 2.44 2.49 - 2.66 2.71 2.2 - 2.25 2.79 2.89 - 3.66 3.73 3.18 - 2.56 -0.63 1.15 - 1.85 2.45 1.33 - 1.74 1.69 1.37 - 1.36 1.15 0.87 - 0.86 0.88 0.73 - 0.64 0.63 0.66 - 0.81 0.71 0.57 - 0.68 0.58 -0.41 - 0.21 0.52 0.39 - 0.45 0.29 0.31 0.4 0.68

ROE %

 9.79 10.02 11.15 10.76 8.30 11.50 11.63 11.58 8.79 10.76 10.70 11.29 8.76 13.91 17.84 20.61 16.95 21.26 14.86 55.90 50.00 57.61 64.24 70.83 23.88 31.93 32.79 29.51 24.17 31.32 29.27 26.81 19.16 24.32 22.21 20.29 14.27 17.53 16.07 15.29 11.22 16.30 17.77 18.39 14.12 19.57 19.11 7.76 3.45 3.39 2.84 1.83 8.45 12.38 14.71 13.04 9.43 14.11 19.94 3.23 4.68 9.76

ROA %

 6.23 6.26 6.92 6.62 5.10 7.02 7.02 6.94 5.23 6.46 6.80 8.18 6.69 10.39 9.16 13.12 10.86 13.74 9.70 37.43 33.48 37.58 40.58 44.29 12.86 17.77 18.84 17.63 14.76 19.38 18.35 17.07 12.40 16.08 15.04 14.07 10.18 12.56 11.59 11.12 8.21 12.08 13.30 13.88 10.76 14.91 14.56 5.91 2.63 2.58 2.20 1.45 6.50 9.46 11.23 9.90 7.13 10.90 15.91 2.44 3.78 7.98

ROCE %

 13.48 14.17 15.65 15.58 12.13 16.50 17.11 17.04 12.94 16.83 17.68 18.36 14.52 21.95 26.00 27.42 22.01 27.49 17.81 12.02 5.38 14.83 22.46 31.23 29.07 39.06 39.41 34.14 27.62 36.18 33.43 28.98 21.14 27.38 25.36 23.48 18.14 22.63 21.38 20.61 15.25 22.10 24.08 24.64 18.87 25.42 24.55 12.07 6.51 7.29 6.94 5.78 11.79 17.15 19.76 17.84 13.03 19.13 27.34 4.28 6.10 13.58

Current Ratio

 2.9 2.7 2.7 2.6 2.6 2.6 2.6 2.6 2.5 2.5 2.5 2.4 2.5 2.7 - 2.6 2.6 2.6 2.7 3.0 3.0 3.0 3.0 3.0 2.2 2.2 2.2 2.2 2.6 2.6 2.6 2.6 2.8 2.8 2.8 2.8 3.5 3.5 3.5 3.5 3.7 3.7 3.7 3.7 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.3 4.3 4.3 4.3 4.1 4.1 4.1 4.1 5.2 5.5

DSO

 97.6 101.5 98.2 95.9 - 94.8 87.4 84.8 - 86.1 81.6 84.4 - 44.0 44.8 86.6 - 74.7 68.9 70.2 - 81.8 170.3 27751.7 - 14437.6 14491.8 17142.7 - 17931.8 20897.0 16002.3 - 16200.6 20529.0 21823.8 - 81.0 83.8 77.6 - 69.7 69.1 66.4 - 62.4 61.5 61.4 - 62.8 63.1 63.0 - 66.2 62.0 64.3 - 66.3 69.6 67.6 60.3 -

DIO

 66.6 60.4 73.5 76.4 - 79.1 80.5 87.9 - 93.5 98.8 105.1 - 54.0 44.6 87.5 - 67.5 59.6 60.8 - 63.5 99.3 73.2 - 60.2 60.7 52.1 - 38.0 40.7 36.4 - 31.2 33.8 35.9 - 35.7 38.6 36.6 - 35.5 34.9 34.4 - 32.4 30.9 31.4 - 32.3 31.8 32.6 - 38.2 37.5 32.6 - 25.6 29.6 23.8 10.6 -

DPO

 37.5 30.7 36.0 35.7 - 33.1 33.3 35.1 - 32.2 38.1 41.7 - 23.4 30.2 60.6 - 70.0 63.2 55.8 - 64.8 101.3 66.8 - 46.9 47.3 47.1 - 43.9 47.0 42.1 - 36.2 39.2 39.9 - 37.6 40.7 49.4 - 62.6 61.6 55.9 - 47.3 45.1 43.1 - 41.0 40.3 41.7 - 49.4 48.4 51.6 - 52.4 60.7 50.6 24.2 -

Operating Cycle

 - 161.9 171.7 172.3 - 173.9 167.9 172.7 - 179.6 180.4 189.4 - 98.0 89.3 174.1 - 142.2 128.5 131.0 - 145.3 269.6 27824.9 - 14497.8 14552.5 17194.8 - 17969.8 20937.7 16038.6 - 16231.7 20562.8 21859.7 - 116.7 122.4 114.2 - 105.2 104.0 100.8 - 94.8 92.4 92.8 - 95.2 94.8 95.6 - 104.4 99.5 97.0 - 91.9 99.2 - - -

Cash Conversion Cycle

 - 131.2 135.7 136.6 - 140.8 134.7 137.6 - 147.4 142.3 147.7 - 74.7 59.2 113.5 - 72.2 65.3 75.1 - 80.4 168.3 27758.0 - 14451.0 14505.2 17147.8 - 17925.9 20890.7 15996.5 - 16195.6 20523.5 21819.8 - 79.1 81.7 64.8 - 42.5 42.4 44.8 - 47.5 47.3 49.7 - 54.1 54.6 53.9 - 55.0 51.1 45.4 - 39.5 38.5 - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Align Technology, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
 		- - $ 1.77 B usaUSA
Avinger Avinger
AVGR
 		- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
 		- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
 		- 24.59 % $ 44.8 M chinaChina
Allied Healthcare Products Allied Healthcare Products
AHPI
 		- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
 		- -5.86 % $ 30.6 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
 		$ 11.2 0.27 % $ 317 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
 		- - $ 475 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
 		$ 8.24 0.24 % $ 1.24 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
 		- 1.37 % $ 20.5 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
 		$ 4.25 -1.62 % $ 159 M franceFrance
BioSig Technologies BioSig Technologies
BSGM
 		- 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
 		- -13.19 % $ 166 K usaUSA
Conformis Conformis
CFMS
 		- - $ 16.4 M usaUSA
LENSAR LENSAR
LNSR
 		$ 5.88 1.38 % $ 70.3 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
 		- 0.15 % $ 844 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
 		$ 2.31 6.94 % $ 50.9 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
 		- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
 		- 1.15 % $ 34.5 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
 		$ 0.47 -0.57 % $ 29.2 M usaUSA
MiMedx Group MiMedx Group
MDXG
 		$ 3.79 4.12 % $ 560 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
 		$ 18.5 1.48 % $ 434 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
 		$ 73.71 1.08 % $ 4.02 B britainBritain
Delcath Systems Delcath Systems
DCTH
 		$ 11.23 3.5 % $ 402 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
 		- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
 		- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
 		- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
 		- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
 		- - $ 111 M canadaCanada
IRIDEX Corporation IRIDEX Corporation
IRIX
 		$ 1.0 -4.76 % $ 16.9 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
 		- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
 		- - $ 10.2 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
 		$ 1.54 14.93 % $ 62.7 M usaUSA
Electromed Electromed
ELMD
 		$ 37.74 -1.64 % $ 319 M usaUSA
Myomo Myomo
MYO
 		$ 0.91 4.17 % $ 38.1 M usaUSA
Butterfly Network Butterfly Network
BFLY
 		$ 4.39 6.94 % $ 1.08 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
 		- - $ 955 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
 		- -0.97 % $ 54.4 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
 		$ 12.15 0.5 % $ 481 M curacaoCuracao
Sintx Technologies Sintx Technologies
SINT
 		$ 2.21 0.45 % $ 6.13 M usaUSA
GBS GBS
GBS
 		- -0.57 % $ 7.12 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
 		$ 6.92 2.82 % $ 209 M canadaCanada
Globus Medical Globus Medical
GMED
 		$ 84.03 5.13 % $ 11.4 B usaUSA
Insulet Corporation Insulet Corporation
PODD
 		$ 156.59 1.28 % $ 11 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
 		$ 37.01 2.29 % $ 1.15 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
 		$ 44.14 3.79 % $ 1.3 B usaUSA
TransMedics Group TransMedics Group
TMDX
 		$ 68.0 2.83 % $ 2.31 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
 		$ 91.49 1.16 % $ 3.18 B usaUSA
Invacare Corporation Invacare Corporation
IVC
 		- - $ 24.7 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
 		$ 82.97 0.99 % $ 48.5 B usaUSA